| |
SPIC's pharmaceuticals portfolio includes:
| - Fermentation-based Penicillin-G—among the world's most cost-effective; |
| - Customs synthesis and contract manufacturing of active pharmaceutical ingredients (apsis), drug intermediates,and synthetic organics compounds. |
| Pencilling G Potassium - Manufacturing & Marketing( Unit at Cuddalore, 200 km from Chennai), only US-FDA plant in Indian and amongst three in the world - the facility can be upgraded and modified for suitable candidate API's based on large fermentation setup (11 x 100 KL) and corresponding utilities. |
| API: |
 R&D - DSIR, Govt. of India, Accredited Centre for Research & Development Synthetic Intermediates & API's, Peptides etc. |
Custom Research, Contract Manufacturing |
Near Patent - expiry API's |
API's for regulated markets |
| Formulations: |
| Finished Dosages (Tablets, Capsules, Liquid {orals} and Powder filling) unit at Maraimalainagar |
| Enzymes: |
| Industrial application based {for Leather, Textile, Poultry & Tea} unit at Maraimalainagar. |
|
| An advanced research center and manufacturing facilities together support SPIC in ensuring that its products confirm to the highest standards of quality, safety and efficacy. |
For more details click here: www.spicpharma.in
|
|